Compare Amazon.com Inc (AMZN) vs Becton Dickinson and Co (BDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amazon.com Inc vs Becton Dickinson and Co — how do they compare? Amazon.com Inc trades at $247.1 (market cap $2.64T), while Becton Dickinson and Co trades at $154.29 (market cap $41.87B). The key difference: Amazon.com Inc is far larger — about 63.1× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays a 2.76% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| AMZN | BDX | |
|---|---|---|
Market Cap | $2.64T | $41.87B |
Volume | 3,931,282 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $274.95 | $185.39 |
52-Week Low | $198.79 | $135.49 |
Enterprise Value | $2.71T | $58.33B |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Amazon (AMZN) trades at $247.31, up 0.8% today, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with revenue growth from $638.0B in 2024 to $716.9B in 2025 and net income rising to $77.7B. Recent news highlights CEO Andy Jassy's optimistic outlook on AWS and AI chip growth, fueling investor confidence.
Outlook remains positive with a consensus price target of $320.75, implying 30% upside. Key risks include intense competition in retail and cloud, high capital expenditures, and macroeconomic pressures. Analysts are overwhelmingly bullish (88.3% buy ratings), viewing Amazon's profit expansion and AI investments as long-term catalysts.
BDX trades at $151.94, up 0.72% on the day, with a bearish technical signal despite recent earnings beats. The stock is supported by consistent revenue growth, reaching $21.84B in 2025, and a forward P/E of 26.52. Analyst consensus is mixed with a $173.40 price target, and the company maintains a solid dividend, recently paying $1.05 per share. Cash flow trends show variability, with 2025 net cash flow negative $1.00B, though 2026 projects a positive $346M.
The outlook for BDX balances strong fundamentals against near-term headwinds. Revenue growth and strategic positioning in medical technology offer upside, but investor sentiment is cautious due to bearish technicals and margin pressures. Risks include hospital spending caution and competitive dynamics. The stock presents a hold case for long-term investors, with potential catalysts from continued earnings outperformance and innovation in healthcare technology.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amazon.com Inc
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →
